In a dermal sensitization study (MRID [number]) with (formulation, note a.i. and %) in (name of vehicle if appropriate or undiluted test article), strain, species (source)(age, weight) were tested using the method of (cite study type). Identify positive control material. List clinical signs (systemic and local for LLNA) and mortality. Necropsy results for LLNA if significant.
(Very briefly note severity and duration of sensitization/ irritation. In this study, Formulation X is (not) a dermal sensitizer. Label comment if applicable.